By peripherally inhibiting hepatic synthesis, hyperinsulinemia decreases serum sex hormone binding globulin (SHBG), favoring free circulating androgens, and decreasing insulin-like growth factor binding protein-1 (IGFBP-1), allowing more IGF-1 to be accessible locally and peripherally. The gene discussed is SHBG; the disease is hyperinsulinism.